Valuation: Getinge AB

Market Cap 64.82B 6.64B 5.75B 5.43B 4.92B 9.24B 636B 9.3B 24.98B 323B 24.93B 24.38B 1,026B P/E 2026 *
20.5x
P/E 2027 * 18.4x
Enterprise Value 73.03B 7.48B 6.48B 6.11B 5.55B 10.41B 717B 10.48B 28.14B 364B 28.08B 27.47B 1,156B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.9x
Free-Float
79.13%
Yield 2026 *
2.17%
Yield 2027 * 2.36%
1 day+1.41%
1 week-3.07%
Current month-4.76%
1 month-2.88%
3 months+17.00%
6 months+23.45%
Current year+3.30%
1 week 24.09
Extreme 24.09
24.77
1 month 24.09
Extreme 24.09
25.98
Current year 18.99
Extreme 18.99
25.98
1 year 18.99
Extreme 18.99
25.98
3 years 14.84
Extreme 14.84
25.98
5 years 14.84
Extreme 14.84
48.89
10 years 8.31
Extreme 8.31
48.89
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%-3.07% - - 6.64B
+0.67%-0.72%+17.28%+18.70% 12.6B
+0.17%-0.58%+12.41%+18.86% 6.64B
-2.36%-5.65% - - 6.18B
+0.06%-1.81%+22.64%+9.53% 5.58B
+2.24%+2.23%-17.26%+43.81% 5.15B
+0.59%-0.20%-34.72%-24.93% 3.78B
+4.58%-9.59%+33.50%-17.33% 1.89B
-1.64%+3.09%-2.91%+182.35% 1.77B
+1.60%-0.16%+46.82%-16.92% 1.59B
Average +0.74%-1.91%+9.72%+26.76% 5.02B
Weighted average by Cap. +0.53%-1.83%+8.68%+20.73%

Financials

2026 *2027 *
Net sales 35.26B 3.61B 3.13B 2.95B 2.68B 5.02B 346B 5.06B 13.59B 176B 13.56B 13.26B 558B 37.24B 3.81B 3.3B 3.12B 2.83B 5.31B 365B 5.34B 14.35B 185B 14.32B 14.01B 589B
Net income 3.17B 324M 281M 265M 240M 451M 31.07B 454M 1.22B 15.76B 1.22B 1.19B 50.11B 3.53B 361M 313M 295M 268M 503M 34.61B 506M 1.36B 17.56B 1.36B 1.33B 55.82B
Net Debt 8.2B 840M 728M 687M 623M 1.17B 80.49B 1.18B 3.16B 40.83B 3.15B 3.08B 130B 5.96B 610M 529M 499M 453M 849M 58.47B 855M 2.3B 29.66B 2.29B 2.24B 94.3B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change Volume
26-09-14 US$24.43 +1.41% 2,906
26-09-11 US$24.09 -0.88% 556
26-09-10 US$24.31 -1.84% 542
26-09-09 US$24.76 -0.60% 605
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
238.00SEK
Average target price
247.60SEK
Spread / Average Target
+4.03%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!